Bausch Health Co. Inc. (BHC) Misses Q4 EPS by $1.22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance
February 23, 2022 6:59 AM ESTLAVAL, Quebec, Feb. 23, 2022 /PRNewswire/ --
Fourth-Quarter 2021 Financial Results Revenues of $2.196 Billion GAAP Net Income of $69 Million Adjusted EBITDA (non-GAAP)1Â of $909 Million GAAP Cash Generated from Operations of $24 Million Full-Year 2021 Financial Results Revenues of $8.434 Billion GAAP Net Loss of $948 Million Adjusted EBITDA (non-GAAP)1 of $3.472 Billion GAAP Cash Generated from Operations of $1.426 Billion Full-Year 2021 Reported Revenue Grew 5% Compared to the Full Year of 2020... More
